BRCA1 and BRCA2 mutations : : diagnostic and therapeutic implications / / Mani T. Valarmathi, editor.
Mutations in the BRCA1/2 genes are the most common cause of hereditary breast and ovarian cancer (HBOC), and HBOC is an autosomal dominant cancer predisposition syndrome. Individuals with HBOC have a high risk for breast and ovarian cancers and a moderate risk for other cancers, such as prostate, pa...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | London : : IntechOpen,, [2023] |
Year of Publication: | 2023 |
Language: | English |
Physical Description: | 1 online resource (134 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
LEADER | 03845nam a2200301 i 4500 | ||
---|---|---|---|
001 | 993603599504498 | ||
005 | 20230627120931.0 | ||
006 | m o d | ||
007 | cr ||||||||||| | ||
008 | 230627s2023 enk o 000 0 eng d | ||
035 | |a (CKB)5580000000514574 | ||
035 | |a (NjHacI)995580000000514574 | ||
035 | |a (EXLCZ)995580000000514574 | ||
040 | |a NjHacI |b eng |e rda |c NjHacl | ||
050 | 4 | |a RC280.B8 |b .B733 2023 | |
082 | 0 | 4 | |a 616.99449 |2 23 |
245 | 0 | 0 | |a BRCA1 and BRCA2 mutations : |b diagnostic and therapeutic implications / |c Mani T. Valarmathi, editor. |
264 | 1 | |a London : |b IntechOpen, |c [2023] | |
300 | |a 1 online resource (134 pages) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
588 | |a Description based on print version record. | ||
520 | |a Mutations in the BRCA1/2 genes are the most common cause of hereditary breast and ovarian cancer (HBOC), and HBOC is an autosomal dominant cancer predisposition syndrome. Individuals with HBOC have a high risk for breast and ovarian cancers and a moderate risk for other cancers, such as prostate, pancreatic, melanoma, and fallopian tube cancers. The goal of screening individuals at high risk of familial cancer is either prevention (such as a change in lifestyle or diet) or early detection of cancer. The identification of BRCA mutation carriers is important, since increased surveillance, drug therapy, and prophylactic surgery can reduce cancer-related morbidity and mortality. In recent years, there has been substantial development in BRCA-associated hereditary breast and/or breast-ovarian cancer research and its clinical applications. In this context, this book consolidates the recent advances in BRCA-related cancer biology and therapeutics, covering a wide spectrum of interrelated topics. Chapters cover a wide range of topics, such as BRCA discovery, BRCA structure and function, BRCA-associated cancers, BRCA genetic testing and counselling, and more. This book is a valuable resource not only for medical and allied health students but also for researchers, clinical and nurse geneticists, genetic counselors, and physician assistants. | ||
505 | 0 | |a Preface. Section 1 Hereditary Breast and Ovarian Cancer Syndrome. Chapter 1 Introductory Chapter: The Influence of BRCA1/2 Genes Mutations on Hereditary Breast and Ovarian Cancer Syndrome Is it in your Genes? by Mani T. Valarmathi Section 2 BRCA Discovery. Chapter 2 Discovery of BRCA Mutations: Historical Perspective of Its Scientific, Clinical and Social Impact by Natalia B. Burachik, Ana Laura Ortiz and Edith C. Kordon Section 3 BRCA Structure and Function. Chapter 3 BRCA Biological Functions by Divya Bhargavi Pulukuri, Vijaya Babu Penke, Divya Jyothi Palati, Prudvi Raj Pulla, Shanker Kalakotla and Siddhartha Lolla. Chapter 4 The Fundamental Role of BARD1 Mutations and Their Applications as a Prognostic Biomarker for Cancer Treatment by Yousef M. Hawsawi and Anwar Shams. Section 4 BRCA-Associated Cancers. Chapter 5 BRCA Gene Mutations and Prostate Cancer by Gvantsa Kharaishvili, Mariam Kacheishvili and Giorgi Akhvlediani. Chapter 6 Genomic Consequences of Ovarian Cancer with Respect to DNA Damage and Repair Mechanism by Sonali Verma, Gresh Chander, Ruchi Shah and Rakesh Kumar. Section 5 BRCA Genetic Testing and Counselling. Chapter 7 Implications of BRCA1 and BRCA2 Mutations in Mexico by Carlos Arturo Gonzalez Nuñez, Paula Anel Cabrera Galeana, Sandy Ruiz Cruz and Alexandra Garcilazo Reyes. Chapter 8 Quality of Life is Essential: Implications for Diagnosis and Treatment for BRCA1/2 Germline Mutations by Yuliana Sanchez Contreras, Brigney Isvettia Aceves Poveda, David Neri Acosta Gutierrez and Rosa Maria Alvarez Gomez. | |
650 | 0 | |a Ovaries |x Cancer. | |
650 | 0 | |a Breast |x Cancer |x Genetic aspects. | |
776 | |z 1-80356-808-9 | ||
700 | 1 | |a Valarmathi, Mani T., |e editor. | |
906 | |a BOOK | ||
ADM | |b 2023-07-06 03:29:09 Europe/Vienna |f system |c marc21 |a 2023-02-11 21:29:23 Europe/Vienna |g false | ||
AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5343038840004498&Force_direct=true |Z 5343038840004498 |b Available |8 5343038840004498 |